Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Stanford University
Hoffmann-La Roche
ViroMissile, Inc.
University of Florida
Barbara Ann Karmanos Cancer Institute
Guerbet
Fusion Pharmaceuticals Inc.
Eli Lilly and Company
Tanabe Pharma America, Inc.
Circle Pharma
Jonsson Comprehensive Cancer Center
MedSIR
Novartis
National Cancer Institute (NCI)
Aminex Therapeutics, Inc.
Rigshospitalet, Denmark
Novartis
Georgetown University
Hoffmann-La Roche
Xencor, Inc.
Provectus Pharmaceuticals
EMD Serono
Novartis
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
AbbVie
SWOG Cancer Research Network
Emory University
Rigshospitalet, Denmark
University of Southern California
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Rutgers, The State University of New Jersey
Mannkind Corporation
National Center for Complementary and Integrative Health (NCCIH)